Page 703 - The Toxicology of Fishes
P. 703

16




                       Biomarkers






                       Daniel Schlenk, Richard Handy, Scott Steinert,
                       Michael H. Depledge, and William Benson



                       CONTENTS
                       Introductory and Historical Perspectives...............................................................................................684
                       Hierarchy of Response...........................................................................................................................686
                       Biochemical Biomarkers........................................................................................................................687
                           Inducible Proteins.........................................................................................................................688
                                CYP1A................................................................................................................................688
                                Metallothioneins .................................................................................................................689
                                Stress Proteins.....................................................................................................................690
                                Multidrug Resistance (P-Glycoprotein) .............................................................................691
                                Phase II Biotransformation Enzymes.................................................................................692
                                Antioxidant Enzymes..........................................................................................................693
                           Endogenous Metabolites ..............................................................................................................694
                                Fluorescent Aromatic Compounds .....................................................................................694
                                Porphyrins...........................................................................................................................695
                                Retinoids .............................................................................................................................696
                           Genotoxic Endpoints....................................................................................................................696
                       Physiological Biomarkers ......................................................................................................................700
                           Hematology and Clinical Chemistry............................................................................................700
                                Blood Sampling Methods...................................................................................................700
                                Hematological Indices ........................................................................................................701
                                Blood or Plasma Ions .........................................................................................................702
                                Blood Metabolites and Enzyme Activities.........................................................................702
                                Circulating Hormones.........................................................................................................702
                           Condition Indices .........................................................................................................................703
                                Condition Factor .................................................................................................................703
                                Organosomatic Indices .......................................................................................................706
                                Growth ................................................................................................................................706
                           Respiratory and Cardiovascular Responses as Biomarkers.........................................................707
                           Behavior as a Biomarker..............................................................................................................708
                       Pathological Biomarkers........................................................................................................................709
                           Morphological Abnormalities ......................................................................................................709
                           Immunohistochemistry.................................................................................................................712
                       Summary ................................................................................................................................................712
                       References..............................................................................................................................................713










                                                                                                   683
   698   699   700   701   702   703   704   705   706   707   708